Dova is a pharmaceutical company that develops drugs for the treatment of cancer and liver diseases.
Business Model:
Revenue: $13.8M
Employees: 51-200
Dova was acquired by
Swedish Orphan Biovitrum.
The acquisition happend on 2019-09-30.
Details of the transaction were not public
Address: 240 Leigh Farm Road
City: Durham
State: NC
Zip: 27707
Country: US
Dova is a pharmaceutical company that develops drugs for the treatment of cancer and liver diseases.
Contact Phone:
+18445063682
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/28/2017
IPO Valuation:
$424M
Ticker Symbol:
DOVA
IPO Price:
$17/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2017 | Post-IPO Equity | 1 | - |
Perceptive Advisors Perceptive Advisors |
9/2016 | Equity | $10M | 6/2017 | IPO | $75.1M | 1/2015 | Seed Round | - | 1/2015 | Venture Round | - | 8/2017 | Post-IPO Equity | 1 | - |
Perceptive Advisors Perceptive Advisors |
1/2015 | Venture Round | - | 1/2015 | Seed Round | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|